GILEAD SCIENCES, INC.

CA

American biotechnology company that researches, develops and commercializes drugs.

Active 2013–2026. The register lists this client once for every firm that files on its behalf; all 17 of its records are shown together here.

Filings
446
Filed By
17
Reported In-House
—
Reported By Firms
$25,975,000

Filings

YearFirmPeriodAmountDoc
2026 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 FARRAGUT PARTNERS LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 MILLER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$150,000
2026 THE MCMANUS GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 W STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 THE DUBERSTEIN GROUP INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$90,000
2026 EMPIRE CONSULTING GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 TIBER CREEK GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2026 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$75,000
Page 1 of 45  ·  446 filings Next
Filed By
FirmFilingsAmount
THE MCMANUS GROUP 56 $3,200,000
FARRAGUT PARTNERS LLP 44 $2,890,000
THE DUBERSTEIN GROUP INC. 32 $2,700,000
TARPLIN, DOWNS & YOUNG, LLC 34 $2,480,000
FORBES-TATE 29 $2,200,000
JEFFREY J. KIMBELL & ASSOCIATES, INC. 31 $2,055,000
EMPIRE CONSULTING GROUP 43 $2,050,000
W STRATEGIES, LLC 32 $1,860,000
BGR GOVERNMENT AFFAIRS 23 $1,280,000
CAPITOL TAX PARTNERS, LLP 42 $1,180,000
TODD STRATEGY GROUP 21 $1,160,000
MILLER STRATEGIES, LLC 7 $880,000
TIBER CREEK GROUP 16 $800,000
THE NICKLES GROUP, LLC 14 $650,000
GRIFFIN CONSULTING, LLC 6 $200,000
THEGROUP DC, LLC 5 $200,000
WALTER CONSULTING 11 $190,000
Issue Areas

Bills Mentioned in Filings